Suppr超能文献

速尿在正常大鼠和蛋白尿大鼠中的处置:尿药-蛋白结合作为药物排泄的决定因素。

Furosemide disposition in normal and proteinuric rats: urinary drug-protein binding as a determinant of drug excretion.

作者信息

Green T P, Mirkin B L

出版信息

J Pharmacol Exp Ther. 1981 Jul;218(1):122-7.

PMID:7241373
Abstract

We have demonstrated recently that the binding of furosemide (FSM) to urinary proteins causes a decrease in the diuretic response that is proportional to the degree of proteinuria. Further studies were conducted to determine whether urinary drug-protein interactions also altered the renal excretion of FSM. Rats were treated with puromycin aminonucleoside to produce proteinuria. Renal FSM clearance was directly related to urinary protein excretion rate (r = 0.550, P less than .005), a relationship that was more striking when FSM clearance was normalized to glomerular filtration rate (r = 0.781, P less than .001). This relationship was not explained by changes in serum protein concentration or glomerular filtration rate. In order to understand the mechanism of this relationship, normal and nephrotic rats were studied during experimental conditions designed to alter urinary pH. In normal animals urinary acidification induced by HCl infusion produced a profound decrease in renal FSM clearance compared to animals with the more alkaline urine that followed NaHCO2 or acetazolamide pretreatment. This alteration in renal FSM clearance during urinary acidification was not observed in nephrotic animals, despite comparable changes in urinary pH. The diuretic response to FSM did not differ among the normal animals despite the alteration in renal FSM clearance, indicating that the reduction of renal FSM clearance was due to tubular reabsorption of FSM distal to its site of action. These data suggest that urinary drug protein binding may impair the tubular reabsorption of drugs and thereby enhance their renal clearance.

摘要

我们最近证实,速尿(FSM)与尿蛋白的结合会导致利尿反应降低,且该降低与蛋白尿程度成正比。我们进行了进一步研究,以确定尿中药物 - 蛋白质相互作用是否也会改变FSM的肾排泄。用嘌呤霉素氨基核苷处理大鼠以产生蛋白尿。肾FSM清除率与尿蛋白排泄率直接相关(r = 0.550,P <.005),当FSM清除率以肾小球滤过率标准化时,这种关系更为显著(r = 0.781,P <.001)。血清蛋白浓度或肾小球滤过率的变化无法解释这种关系。为了理解这种关系的机制,在旨在改变尿pH值的实验条件下研究了正常和肾病大鼠。在正常动物中,与用NaHCO2或乙酰唑胺预处理后尿液更碱性的动物相比,HCl输注诱导的尿液酸化导致肾FSM清除率大幅降低。尽管尿pH值有类似变化,但肾病动物在尿液酸化过程中未观察到肾FSM清除率的这种改变。尽管肾FSM清除率发生了变化,但正常动物对FSM的利尿反应并无差异,这表明肾FSM清除率的降低是由于FSM在其作用部位远端的肾小管重吸收所致。这些数据表明,尿中药物与蛋白质的结合可能会损害药物的肾小管重吸收,从而提高其肾清除率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验